Caricamento...
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Nivolumab is a programmed death receptor 1 (PD-1) inhibitor. It is part of a group of drugs known as immune checkpoint blockers, which enable potent and durable T-cell responses against several tumors. We report the case of a patient with a metastatic squamous cell carcinoma, who is being treated wi...
Salvato in:
| Pubblicato in: | Case Rep Dermatol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
S. Karger AG
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7315375/ https://ncbi.nlm.nih.gov/pubmed/32595466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000505478 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|